Inflammatory indexes as predictors of prognosis and bevacizumab efficacy in patients with metastatic colorectal cancer.
Passardi A, Scarpi E, Cavanna L, Dall'Agata M, Tassinari D, Leo S, Bernardini I, Gelsomino F, Tamberi S, Brandes AA, Tenti E, Vespignani R, Frassineti GL, Amadori D, De Giorgi U.
Passardi A, et al. Among authors: bernardini i.
Oncotarget. 2016 May 31;7(22):33210-9. doi: 10.18632/oncotarget.8901.
Oncotarget. 2016.
PMID: 27120807
Free PMC article.
Clinical Trial.